Analytical Data
-
Gene name
SAGE1
- Application
-
Alternative Names
Cancer/testis antigen 14; CT14; RP11-97N5.1; SAGE; SAGE1; SAGE1_HUMAN; Sarcoma antigen 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NXZ1
-
Expression Region
357-455 aa
-
AA Sequence
PLPSNALSTVLPGLAYLATADMPAMSTRDQHATIIHNLREEKKDNSQPTPDNVLSAVTPELINLAGAGIPPMSTRDQYATVNHHVHEARMENGQRKQDN
-
Molecular Weight
36.63 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SAGE1, a protein associated with the diagnosis and treatment of various diseases, has garnered significant attention in recent years due to its unique structural features and functional roles in cellular processes. Research indicates that SAGE1 may play a critical role in cell signaling, apoptosis, and immune response, making it a potential target for therapeutic interventions. Its involvement in pathological conditions, such as cancer and autoimmune disorders, highlights the importance of understanding SAGE1's mechanisms of action. Recent advancements in recombinant protein technology have enabled the production and characterization of SAGE1, allowing researchers to explore its biological functions in detail. Moreover, studies on SAGE1 have led to the development of specific inhibitors and biomarker applications, thus paving the way for innovative strategies in drug discovery and personalized medicine. The ongoing research on SAGE1 not only provides insights into its biological significance but also opens new avenues for potential clinical applications, emphasizing the need for continued exploration of this intriguing protein.
